HEMATOLOGICAL MALIGNANCY
Clinical trials for HEMATOLOGICAL MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCY trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Blood clotting treatment studied for chemo patients with stubborn bleeding
Disease control TerminatedThis study looked at whether a clotting protein called fibrinogen could help control bleeding in blood cancer patients whose platelet counts are very low after chemotherapy and who don't respond to platelet transfusions. Only 1 patient was enrolled before the study was stopped ea…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated Jun 18, 2026 11:51 UTC
-
Liver function and cancer drug: a safety check
Knowledge-focused TerminatedThis study looked at how the cancer drug tazemetostat stays in the blood of people with advanced tumors and different levels of liver function. Researchers compared patients with moderate or severe liver impairment to those with normal livers. The goal was to understand how the l…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: PHASE1 • Sponsor: Epizyme, Inc. • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:53 UTC